Information Journal Paper
APA:
Copy. (2019). West German Study PlanB Trial: adjuvant four cycles of epirubicin and cyclophosphamide plus docetaxel versus six cycles of docetaxel and cyclophosphamide in HER2-negative early breast cancer. JOURNAL OF CLINICAL ONCOLOGY, 37(10), 799-808. SID. https://sid.ir/paper/785000/en
Vancouver:
Copy. West German Study PlanB Trial: adjuvant four cycles of epirubicin and cyclophosphamide plus docetaxel versus six cycles of docetaxel and cyclophosphamide in HER2-negative early breast cancer. JOURNAL OF CLINICAL ONCOLOGY[Internet]. 2019;37(10):799-808. Available from: https://sid.ir/paper/785000/en
IEEE:
Copy, “West German Study PlanB Trial: adjuvant four cycles of epirubicin and cyclophosphamide plus docetaxel versus six cycles of docetaxel and cyclophosphamide in HER2-negative early breast cancer,” JOURNAL OF CLINICAL ONCOLOGY, vol. 37, no. 10, pp. 799–808, 2019, [Online]. Available: https://sid.ir/paper/785000/en